$CBDW 1606 Corp. Partners with Cool Blue To Launch ChatCBD,

New Post Public Reply Private Reply Replies (0) Message Board
louied91
107
$CBDW 1606 Corp. Partners with Cool Blue To Launch ChatCBD, a New AI Customer Experience

https://www.prnewswire.com/news-releases/1606...38314.html

SEATTLE, Sept. 26, 2023 /PRNewswire/ -- 1606 Corp. (OTC Pink: CBDW) ("1606" or the "Company" is excited to announce an upcoming launch of ChatCBD, the Company's revolutionary AI chatbot designed to transform customer experiences. This conversational e-commerce tool will initially be installed in partnership with Cool Blue Distribution. Under this agreement, 1606 will install its proprietary AI merchandizing ChatBot on Coll Blue's website. ChatCBD has been specifically designed to answer customer questions about CBD and make product recommendations from retail brands currently being offered by Cool Blue Distribution which is a top CBD distributor in the U.S. (For a full list of retailers see www.CoolBlueDist.com).

This merchandizing AI provides 1606 with new channels of revenue from licensing, product sales, payment processing and more. Conversational e-commerce technology personified by 1606's new merchandising Chatbot opens the door for the Company to enter bigger markets such as nutraceuticals, cosmetics, and supplements to name a few.

One of the largest problems in online sales of CBD products, as expressed by real CBD users, is that as consumers they are inundated with hundreds of product choices at a time resulting in a lack of understanding due to the unregulated status of the CBD industry. More often than not, this results in cart abandonment, lost sales, and a lack of trust in the industry. CBD customers are comfortable discussing their CBD uses, dosages, and product type with a knowledgeable CBD expert more typically found in a dedicated CBD retail location (CBD Shops). ChatCBD doubles as an in-store resource for CBD retailers allowing employees to advise and educate at a scale previously unavailable to the industry. When it comes to CBD, online sales remain the dominant distribution channel, accounting for 66% of overall sales according to American Marijuana.Org, and 1606, in partnership with Cool Blue, will aim to blend the best brick-and-mortar CBD customer service and online product selection with the use of the new AI ChatBot, ChatCBD.

Key Features of ChatCBD:

Natural Language Processing (NLP): ChatCBD leverages state-of-the-art NLP technology, enabling her to understand and respond to customer queries with human-like precision and comprehension.
24/7 Availability: ChatCBD is always available to assist customers, ensuring round-the-clock support and resolving issues promptly, even outside of regular business hours.
Seamless Integration: ChatCBD seamlessly integrates with existing customer support systems, allowing businesses to enhance their services without disrupting their current workflows.
Personalized Engagement: ChatCBD can personalize interactions by analyzing customer data, preferences, and behavior patterns, delivering tailored solutions and recommendations.
Multi-Platform Compatibility: ChatCBD can be deployed across various digital platforms, including websites, social media, and messaging apps, providing a consistent and accessible customer experience.
Scalability: ChatCBD capabilities can scale with your business, adapting to increased customer demands without compromising on performance.
Data Analytics: ChatCBD collects and analyzes customer interaction data to provide valuable insights, enabling businesses to make informed decisions and optimize their services.
The CEO of 1606 Corp., Greg Lambrecht, expressed enthusiasm about the launch, stating, "ChatCBD marks a significant milestone in our commitment to empowering businesses with AI technology. We believe that ChatCBD advanced AI capabilities will revolutionize how companies engage with their customers, fostering loyalty and trust in an increasingly competitive marketplace."

Early adopters of ChatCBD will experience substantial improvements in customer satisfaction, reduced response times, and increased efficiency in their customer service operations. As CBD businesses continue to adapt to evolving consumer expectations, ChatCBD stands as a powerful tool for delivering exceptional customer experiences.

To learn more about ChatCBD and how 1606 Corp. can help your business leverage this groundbreaking AI chatbot, please visit www.CBDW.ai or contact our head of business development, Austen Lambrecht at austen@1606corp.com.

Why ChatCBD and why now? A Forbes Health Survey of 2,000 U.S. adults conducted by OnePoll found 60% of respondents have tried a CBD product and believe it offers some medicinal benefits. According to a 2018 cross-sectional survey of over 2,400 people published in Cannabis and Cannabinoid Research, almost 62% of CBD users report using the cannabinoid to treat a medical condition specifically. The top three medical conditions treated with CBD include pain, anxiety and depression according to Forbes.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 421

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 253

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 281

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
Johnson & Johnson Unveils Promising PsA Treatment Data

Updated Category News Views 282

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 34

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
NatGold Pulling NATG From MEXC Amid Security Concerns

Updated Category News Views 536

NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...

Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease

Updated Category News Views 462

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 547

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
2027 Toy of the Year Finalists Energize Play Market

Updated Category News Views 308

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 243

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading

Top 5 Most Recently Viewed Articles

Silexion Therapeutics to Showcase Innovations at Upcoming Conference

Updated Category News Views 127

Silexion Therapeutics and Its Future in Oncology Silexion Therapeutics Corp. is at the forefront of the biotechnology sector, focusing its efforts on innovative treatments specifically designed for oncology. This clinical-stage company is dedicated to transforming the landscape for patients with hard-to-treat cancers, primarily those with the mutated KRAS oncogene, known...

Continue Reading
UBS Predicts Slowdown in Nvidia-Led Tech Rally - Key Insights

Updated Category News Views 172

UBS Foresees Changes in Tech Rally Dynamics Analysts at UBS suggest that the excitement surrounding the recent tech rally, driven by Nvidia, is beginning to wane. They predict a shift towards a more volatile market environment, influenced by ongoing economic challenges and increasing regulatory scrutiny in the semiconductor sector. Analysts' Perspectives on Future Stock...

Continue Reading
OS Therapies (OSTX) Unveils Encouraging Survivorship Data

Updated Category News Views 222

OS Therapies Inc. Reports Promising Results in Bone Cancer Therapy OS Therapies Inc. (NYSE: OSTX), a company focused on developing innovative cancer treatments, recently reported compelling findings from its Phase 2b clinical trial on OST-HER2, an off-the-shelf immunotherapy designed for addressing osteosarcoma, a challenging form of bone cancer. Significant Survival Data...

Continue Reading
Jeito Capital Boosts Aviceda Therapeutics with $207.5M Funding

Updated Category News Views 239

Jeito Capital's Strategic Investment in Aviceda Therapeutics Jeito Capital has recently announced a significant investment in Aviceda Therapeutics, securing a substantial participation in an upsized $207.5 million Series C financing round aimed at advancing the company's lead program, AVD-104. This funding is specifically intended to support pivotal trials for AVD-104,...

Continue Reading
Apple's Innovative M4 Mac Mini Sets New Standards in Tech

Updated Category News Views 293

Apple Launches the Game-Changing Mac Mini Apple Inc (NASDAQ: AAPL) has once again captivated technology enthusiasts and consumers alike with its latest innovation — the redesigned Mac mini equipped with groundbreaking M4 and M4 Pro chips. This launch not only showcases Apple's commitment to performance but also its pioneering approach to sustainability, marking the Mac...

Continue Reading